The aims of the HYDRA project are to: i) characterize the active cis-regulators using integrated multi-omics in patient derived organoids (PDOs) fr
The goal of this project is to identify conserved, targetable processes and markers mis-regulated in
The goal of our project is to identify the key AS events modulated by these drugs that induce cell proliferation